Drug manufacturer Bausch Health announced it will exempt all Arkansas providers and pharmacies from its 340B contract pharmacy policy, including [...] …
Category: Pharma Industry
Japanese drugmaker Takeda recently announced refunds to 340B covered entities for 28 drugs, including one of its top-selling attention-deficit medications. [...] …
Attorneys for both covered entities and drug manufacturers say they expect a significant number of filings to the newly re-established [...] …
Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...] …
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...] …
Drugmakers AbbVie and Boehringer Ingelheim (BI) have agreed in principle to exempt Arkansas providers from their 340B contract pharmacy restrictions, [...] …
Merck has added an injectable medication used to treat pulmonary arterial hypertension—a type of high blood pressure which affects the [...] …
Breaking News
HRSA Issues Final Regulations Revamping Process to Resolve Disputes Between 340B Providers and Manufacturers
The federal government issued the final rule early Thursday to implement a long-anticipated revision to the 340B Administrative Dispute Resolution [...] …
After missing its self-imposed deadline of the end of 2023, the White House this week completed its review to implement [...] …
An influential drug industry trade group has asked a full federal appeals court to rehear a case on the constitutionality [...] …